This effect was mitigated by neutralizing CCL2, which reduced macrophage aggregation, inhibited TGF-β induction, curtailed fibroblast proliferation, alleviated diastolic dysfunction, and reduced myocardial fibrosis. Here, TGFB1 is linked to Myocardial fibrosis.